Your session is about to expire
← Back to Search
Ensifentrine for Chronic Obstructive Pulmonary Disease
Study Summary
This trial will test if a new drug called ensifentrine is safe and helpful for people with moderate to severe COPD.
- Chronic Obstructive Pulmonary Disease
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 3 trial • 763 Patients • NCT04535986Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many staff members are needed to manage this research project?
"Presently, the study is being conducted in 36 different centres, which are situated in Abingdon, Monroe, Miami and other cities. If you wish to take part in this research project, it would be advantageous to choose a location close to your home to minimize travel requirements."
Has this type of trial been conducted before?
"Ensifentrine's clinical trials started in 2020. The first study, sponsored by Iqvia Pty Ltd., was completed that year with a sample size of 800. After Phase 3 drug approval, the only active Ensifentrine study today is once again being sponsored by Iqvia Pty Ltd."
Does this research project have an age limit?
"People who meet the age requirements of 40 to 80 years old are able to apply for this clinical trial. In contrast, there are 15 trials available for minors and 346 trials open to senior citizens."
How large is the sample size for this experiment?
"Currently, this research study is not recruiting patients. The trial was created on September 29th, 2020 and edited last on October 31st, 2022. There are other studies you can explore; as of now, there are 1 trials for Ensifentrine actively searching for patients and 351 studies actively enrolling patients with chronic obstructive airway disease."
Are there any other scientific papers that mention Ensifentrine?
"Ensifentrine was first trialled in 2020 at the Korea University Anam Hospital. Since then, 18295 more clinical trials have completed. As of now, there is 1 active clinical trial recruiting patients. This particular trial is based out of Abingdon, Virginia."
Is it legal to market and distribute Ensifentrine in the United States?
"There is prior clinical data supporting Ensifentrine's safety, so it received a score of 3."
Are new participants being allowed to join this clinical trial at this time?
"Although not currently recruiting patients, this study was first posted on September 29th 2020. The trial has since been updated on October 31st of this year. There are 352 other trials that are actively searching for participants which you can view here."
If I wanted to, could I join this clinical trial?
"This study is recruiting 800 patients with chronic obstructive airway disease aged 40 and 80. Most notable, candidates are required to meet the following criteria: -Smoking History: Current or former cigarette smokers with a history of cigarette smoking ≥10 pack years at Screening (Visit 0) [number of pack years = (number of cigarettes per day / 20) × number of years smoked (eg, 20 cigarettes per day for 10 years, or 10 cigarettes per day for 20 years)]. Pipe and/or cigar use cannot be used to calculate pack-year history. Former smokers are defined as those who have stopped smoking for"
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Most responsive sites:
- IMA Clinical Research, LLC: < 48 hours
Average response time
- < 2 Days
Typically responds via
Share this study with friends
Copy Link
Messenger